Skip to main content

Table 3 Cobas HBVDNA levels and Determination of lamivudine resistance sites

From: Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed Western Region in China---case report and review of the literature

  HBVDNA manufactured in China Cobas HBVDNA(IU/ml) Determination of lamivudine resistance
  < 103cps/ml None
  < 103cps/ml None
2013–11 < 500 IU/ml 91 YMDD tolerance
2014–10 < 500 IU/ml 45 Can’t measure
2016–06 < 500 IU/ml 70 unmeasured
2017–12 < 500 IU/ml 76 unmeasured